Grounded in science, elevating the standard

Jason Ackerman was appointed to the TerrAscend Board of Directors and named to the role of Executive Chairman in November 2019. Jason is the founder of FreshDirect, a pure-play home delivery grocer that pioneered e-commerce in the US, defining a unique and profitable operating model that is customer-centric, hyper-fresh, focused on relationships with producers, and technologically innovative. Over 20 years he served various senior roles including President, CFO and CEO & Chairman. More recently in 2016, Jason also founded Foodkick, where he designed and assembled a team to build a new same-day hourly service. Jason has deep knowledge of retail e-commerce, especially in online grocery strategy and logistics across the spectrum of pure-play to brick-and-mortar retailers. He has strong experience operationalizing strategy – be it with org structure & talent, technology vision, or go-to market (marketing and product development). Jason is also experienced in operations and logistics topics, including design networks, picking methods (and related technologies) and last mile delivery. He is a consumer centric thinker and firmly believes in metric-driven management. He is a Senior Advisor at The Boston Consulting Group and actively involved in digital transformation and strategies.

TerrAscend’s co-founder and CEO, Dr. Michael Nashat, Pharm. D., has over 12 years of experience in patient care, quality assurance, medical and regulatory affairs and R&D. Prior to co-founding TerrAscend, Dr. Nashat cofounded and was the Executive Director of OnPharm Independent Pharmacy Group, the largest independent non banner group in Canada with over 500 pharmacies. Dr. Nashat is a former board member of the Canadian Association of Chain Drug Stores, Ontario College of Pharmacists and the Canadian Foundation for Pharmacy. Dr. Nashat is a former member of the Ontario Ministry of Health and Long Term Care’s Pharmacy Council and the former Vice Chair of the Ontario Pharmacists Association’s Owners Advisory Council. Dr Nashat received his Doctor of Pharmacy Magna Cum Laude from the Albany College of Pharmacy and Health Sciences and completed his Post-Doctoral Fellowship in Neuroscience Medical Strategy at Rutgers University and Bristol-Myers Squibb.

Adam Kozak brings a wealth of experience from Loblaw Companies Limited.  During his 10-year tenure, Adam led initiatives in mergers and integration, process re-engineering and analytics. Prior to Loblaw, Adam also held positions at Deloitte and Wormald Masse Keen Lopinski.

Brian has 20+ years of experience advising on investments, transactions, securities regulation, and compliance. Prior to joining TerrAscend, Brian held positions at Sound Point Capital Management and Fried Frank, Harris, Shriver & Jacobson.

Ms. Molloy joined the Company in May 2018 and has played an integral role in executing the Company’s growth strategy. She led the Company’s Arise Bioscience, The Apothecarium, State Flower and Ilera Healthcare transactions, and will oversee the strategic integration of those businesses into the Company with the guidance of Jason Ackerman. Ms. Molloy has extensive experience in the cannabis market and over 20 years prior experience in finance, structured credit, capital markets and investing, having spent most of her career at Swiss Re.

Joanna has over 12 years of human resources, operational execution and strategic leadership experience within retail and manufacturing sectors. She has worked extensively with investment professionals of private equity in leading change management in M & As, execution of multi-faceted strategic growth, talent acquisition, policies and governance. A strong partner, who values the importance of the individual as well the team fostering development through strong, meaningful strategies.

Jason Wild is the President and Chief Investment Officer of JW Asset Management, LLC, and the advisor for five investment partnerships with approximately $1 billion in assets under management. Mr. Wild received his license as a pharmacist in 1997, and subsequently founded JW Asset Management, LLC in 1998. The firm has a strong history of finding opportunities within the healthcare sector. He is a graduate of the Arnold and Marie Schwartz College of Pharmacy. Mr. Wild is the Chairman of the Board of TerrAscend Corp. and Arbor Pharmaceuticals. He is a board member of Vensun Pharmaceuticals and Vitruvias Therapeutics. Funds managed by JW Asset Management, LLC are the largest shareholders in TerrAscend Corp. Mr. Wild is also a board member of NETA NJ LLC where he will be actively involved in planning and directing the organization’s strategic and long-range goals.

Jason Ackerman was appointed to the TerrAscend Board of Directors and named to the role of Executive Chairman in November 2019. Jason is the founder of FreshDirect, a pure-play home delivery grocer that pioneered e-commerce in the US, defining a unique and profitable operating model that is customer-centric, hyper-fresh, focused on relationships with producers, and technologically innovative. Over 20 years he served various senior roles including President, CFO and CEO & Chairman. More recently in 2016, Jason also founded Foodkick, where he designed and assembled a team to build a new same-day hourly service. Jason has deep knowledge of retail e-commerce, especially in online grocery strategy and logistics across the spectrum of pure-play to brick-and-mortar retailers. He has strong experience operationalizing strategy – be it with org structure & talent, technology vision, or go-to market (marketing and product development). Jason is also experienced in operations and logistics topics, including design networks, picking methods (and related technologies) and last mile delivery. He is a consumer centric thinker and firmly believes in metric-driven management. He is a Senior Advisor at The Boston Consulting Group and actively involved in digital transformation and strategies.

TerrAscend’s co-founder and CEO, Dr. Michael Nashat, Pharm. D., has over 12 years of experience in patient care, quality assurance, medical and regulatory affairs and R&D. Prior to co-founding TerrAscend, Dr. Nashat cofounded and was the Executive Director of OnPharm Independent Pharmacy Group, the largest independent non banner group in Canada with over 500 pharmacies. Dr. Nashat is a former board member of the Canadian Association of Chain Drug Stores, Ontario College of Pharmacists and the Canadian Foundation for Pharmacy. Dr. Nashat is a former member of the Ontario Ministry of Health and Long Term Care’s Pharmacy Council and the former Vice Chair of the Ontario Pharmacists Association’s Owners Advisory Council. Dr Nashat received his Doctor of Pharmacy Magna Cum Laude from the Albany College of Pharmacy and Health Sciences and completed his Post-Doctoral Fellowship in Neuroscience Medical Strategy at Rutgers University and Bristol-Myers Squibb.

Richard Mavrinac held positions as CFO for George Weston Limited and Executive VP of Loblaw Companies and has extensive expertise in public company finance and strategy.

Craig Collard is the CEO of Veloxis Pharmaceuticals, a commercial-stage specialty pharmaceutical company committed to improving the lives of transplant patient and has over 20 years of experience in the pharmaceutical industry. Mr. Collard has a proven track-record of leadership, managing organizational change, and driving successful merger and acquisition activity. Prior to Veloxis, Mr. Collard was the Founder and CEO of Cornerstone Therapeutics, a company focused on hospital, respiratory and adjacent specialty markets.

Lisa has 20+ years of experience in manufacturing, distribution, and retail, previously holding senior financial positions with some of Canada’s largest publicly-traded corporations. A strategic thinker with diverse experience in leading growth, Lisa has advised mid-market privately held companies in both the United States and Canada. Lisa holds a BA (Economics) from Western University, and an MBA from Queen’s University, and also holds the Institute of Corporate Directors ICD.D (Certified Director) designation.